Brian Elsbernd - Mar 27, 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Compliance/Legal Officer
Signature
/s/ Brian Elsbernd
Stock symbol
CPRX
Transactions as of
Mar 27, 2024
Transactions value $
-$411,000
Form type
4
Date filed
3/28/2024, 04:45 PM
Previous filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Sale -$411K -25K -16.73% $16.44 124K Mar 27, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold on the open market to fund payment of a personal tax liability and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $16.42 to $16.47 per share.